SLC26A4 and hearing loss disorder: To conclude, in our central European Caucasian cohort with hearing loss and non-syndromic EVA, a combined genetic analysis approach prioritizing formerly known EVA-related genes detected biallelic pathogenic variants of SLC26A4 in 5/32 patients (16%), monoallelic pathogenic SLC26A4 variants with CEVA haplotype in 3/32 patients (9%), and a biallelic CEVA haplotype in 1/32 patients (3%).